Carlye Group Invests $250 Million in Pharmapacks

Pharmapacks, a leading online pharmacy retailer, has secured a $250 million dollar investment from the Carlyle Group, bringing its overall valuation to $1.1 billion. This comes as the demand for online goods continues to grow amid the coronavirus pandemic. Andrew Vagenas, CEO of Pharmapacks, joined Wake Up With Cheddar for more.
We use cookies and similar technologies on this site to collect identifiers, such as IP address, and cookie and device IDs as described in our Privacy Policy.